2. About StemRx
We at StemRx Bio Science Solutions Pvt. Ltd apply
the regenerative powers of stem cells and help our
patients to
halt the aging degenerative process
improve the quality of life
maintain a young look
rejuvenate in the inside, with better functioning, re-energized and
healthy organs
bring the benefits of bioscience to patients who have been diagnosed
with chronic debilitating diseases
offer viable and efficient therapeutic options.
3. Dr. P. V. Mahajan is the Founder Chairman and the
Managing Director
A surgeon by qualification
Established the first Industrial Trauma Care centre in the
then remote area of Navi Mumbai
A visionary with business orientation, spread out wings in
corporates, in diagnostics and allied areas of health care
With hard core interest in academics, got trained in
Austria and in the US for novel domain of regenerative
medicine
4. Founded StemRx Bioscience Solutions after having
convinced himself that today’s conventional modalities of
treatment ONLY take care of the signs and symptoms.
They DO NOT address the route cause of the disease or
the ailment.
This is especially true in the case of degenerative
debilitating diseases of the old age.
5. Indications treated….
Avascular necrosis
Severe chronic osteoarthritis
Rheumatoid arthritis
Diabetes type 1 and 2 and complications
Ankylosing spondylitis
Motor Neuron Disease
Muscular Dystrophies
Lung diseases and other respiratory diseases
Liver cirrhosis
Multiple sclerosis
Ligament tear and other sports injuries
Cerebral palsy
Parkinson’s disease
Until now, more than 75 different indications have been successfully undertaken by
StemRx….
More than 2000 patients with degenerative debilitating problems have been treated and
have gone back happily…
6. Expansion to Seven Hills Hospital
First ever tie-up in India with a corporate hospital
Spread over 7000 Sq ft
World-class GMP compliant processing and research facility, fully equipped
for progressive research
Academic and Research affiliation with
Ohio State University
Maharashtra University of Health Sciences
Patent
Filed a patent for novel cell based treatment modality for Avascular Necrosis
Publications
Four international publications (Dr. Mahajan)
More than 10 by Dr. Anand Kumar, RnD Director
Regulatory status
Application under review at the NAC-SCRT
GMP certification in process
7. Our Achievements
Filed a patent for “Non
Surgical treatment of
Avascular Necrosis using
Autologous Bone Marrow
Mesenchymal Biomaterials”
10. Our Publications and Articles
“Antidotes and Management of Chemical Poisoning” ,
Written and Published (Book)
“Changing Paradigms in Health Medicine”; Indian Journal of
Stem Cell Therapy 1 (1), 50-53 June 2015.
“Evaluation of suture materials in surgical wounds.”
“Study of Cell Therapy Assisted Regeneration of Cartilage in
Avascular Bone Necrosis.” D. Y. Patil Journal of Health Sciences,
2(1): 41 – 45, 2014.
“Stem Cell Medicine and Therapeutic Application of Stem
Cell”, INAR VII and Journal of SCSI, March 2014.
“Revamping of Regenerative Medicine.” Health Science
Innovation (Abstract), January, 2015.
“Stem cell niche and Therapeutic Application of Stem Cells.”
Stem Cell Society of India and Indian Federation of Neuro
Rehabilitation (Abstract), March 2014.
11. Increasing the patient
base
Offering all allied
services for maximum
patient benefit
Will start with PG-
Fellowship under the
banner of MUHS very
soon
Initiating research
portfolio
12. Equal thrust on all three
activities
Go global in
therapeutics by tie-ups
with hospitals across the
borders
Expand academics to
PhD and post-doc level
Involve pharmaceuticals
for stem cells in drug
development programs